Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance

Overview of attention for article published in Proceedings of the National Academy of Sciences of the United States of America, July 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news: 6 news outlets
twitter: 8 X users

patent: 5 patents

Readers on

mendeley: 87 Mendeley

So far, Altmetric has seen 5 patents that reference this research output.

Pantothenamide analogues

Grant US-11834391-B2

United States of America

05 Dec 2023

Pantothenamide analogues

Grant US-11572336-B2

United States of America

07 Feb 2023

ARTEMISININ-PROTEASOME INHIBITOR CONJUGATES AND THEIR USE IN THE TREATMENT OF DISEASE

Application WO-2022159581-A3

World Intellectual Property Organisation (WIPO)

09 Sep 2022

PANTOTHENAMIDE ANALOGUES

Application WO-2020141155-A1

World Intellectual Property Organisation (WIPO)

09 Jul 2020

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 1 additional patents.